Get the Daily Brief
Latest Biotech News
Neuralink Files as Disadvantaged Business Amid $9 Billion Valuation
Neuralink, Elon Musk’s brain-computer interface startup developing technology to help paralyzed patients, recently classified itself as a 'small disadvantaged business' (SDB) in a federal filing....
FDA Approves Insmed’s Brensocatib for Non-CF Bronchiectasis
The FDA approved Insmed's Brensocatib, the first drug sanctioned to treat non-cystic fibrosis bronchiectasis (NCFB). This milestone brings a new targeted therapy to roughly 500,000 affected...
Stem Cell Technique Advances Human Meiosis Modeling for Infertility
Researchers at Harvard’s Wyss Institute developed a novel stem cell differentiation method that directly induces meiosis in human induced pluripotent stem cells, circumventing previous barriers...
Amyloid Beta Disrupts Microglia via Lipid Droplets in Alzheimer's
New research from Purdue University reveals amyloid β plaques trigger lipid droplet accumulation in microglia, impairing their ability to clear plaques and promoting sustained inflammation in...
Hatteras Venture Closes $200M Fund Amid VC Slowdown
Despite a challenging venture capital environment, Hatteras Venture Partners closed two new investment funds totaling $200 million, focused on seed- and early-stage biotech companies. The firm's...
Trojan Horse Bacteria Deliver Oncolytic Viruses in Cancer Therapy
Scientists engineered bacteria as Trojan horses to transport cancer-killing viruses directly into tumor cores, bypassing immune clearance. This targeted delivery system enables the virus to...
China’s Wuxi Emerges as Cost-Effective Pharma Biotech Hub
Wuxi, near Shanghai, is rapidly establishing itself as a premier biotech cluster, attracting global pharmaceutical companies seeking faster, cheaper drug development and manufacturing. Unlike U.S....
Meta-Analysis Links Environmental Sensitivity to Mental Health Risks
A comprehensive meta-analysis of 33 international studies establishes a robust association between high environmental sensitivity and increased incidence of common mental disorders including...
Dexamethasone Lower Dose Effective in Preventing Chemotherapy Reactions
A recent randomized controlled trial published in BMC Cancer demonstrated that a 10 mg dose of dexamethasone is non-inferior to higher doses in preventing hypersensitivity reactions (HSRs) from...
Nab-Paclitaxel Plus Cisplatin Outperforms Gemcitabine in Biliary Cancer
A multicenter phase II study in BMC Cancer reports that nab-paclitaxel combined with cisplatin shows superior efficacy versus gemcitabine therapy in advanced biliary tract cancer. Results indicate...
China's Biotech Hub Challenges US Dominance in Cost and Speed
China's biotechnology sector is rapidly expanding, leveraging a strategy that focuses on speeding up drug manufacturing and reducing costs. Wuxi, near Shanghai, has become a major hub where...
Trojan Horse Bacteria Deliver Viruses Against Tumors
Scientists have developed a novel cancer treatment employing engineered bacteria to transport oncolytic viruses directly into tumors, effectively evading immune detection. This 'Trojan horse'...
Hatteras Venture Closes $200M Funds Amid Fundraising Challenges
In a challenging fundraising environment for venture capital, Hatteras Venture Partners successfully secured $200 million for two new funds targeting seed- and early-stage biotech companies. This...
FDA Approves Jazz Pharmaceuticals' Drug for Rare Brain Tumor
The US Food and Drug Administration has granted approval to a new therapy developed by Jazz Pharmaceuticals targeting a rare form of brain tumor. This regulatory milestone provides a novel...
Metabolic Inflammation Model Links to Adolescent Reproductive Dysfunction
Recent research uncovers a novel connection between metabolic inflammation in the hypothalamus and reproductive issues in teenagers. This new model highlights the role of neuroinflammatory...
Clinical Trial Shows Nab-Paclitaxel Combo Outperforms Gemcitabine in Biliary Cancer
A multicenter phase II clinical trial has demonstrated that a chemotherapy regimen combining nab-paclitaxel with cisplatin delivers superior efficacy compared to gemcitabine in treating advanced...
Blood Test Predicts Immunotherapy Success in Triple-Negative Breast Cancer
Researchers at Fudan University Shanghai Cancer Center have identified a novel blood biomarker capable of forecasting patient response to immunotherapy in triple-negative breast cancer (TNBC)....
NIH Awards $14.9M Grant for Innovative HIV Persistence Research
A multi-institutional team led by Weill Cornell Medicine received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases to pursue breakthrough strategies...
Large Language Models Transform Drug Development Pipeline
Cutting-edge artificial intelligence, particularly large language models (LLMs), are reshaping drug discovery and development processes. These advanced AI architectures accelerate molecule design,...
Platelets' Emerging Role in DNA Surveillance and Cancer Detection
New scientific insights reveal that platelets possess functions extending beyond traditional blood clotting, including active roles in detecting DNA damage and participating in cancer...